Improvements in genome sequencing technology increased the availability of full genomes and transcriptomes of many organisms. However, the major benefit of massive parallel sequencing is to better understand the organization and function of genes which then lead to understanding of phenotypes. In order to interpret genomic data with automated gene annotation studies, several tools are currently available. Even though the accuracy of computational gene annotation is increasing, a combination of multiple lines of experimental evidences should be gathered. Mass spectrometry allows the identification and sequencing of proteins as major gene products; and it is only these proteins that conclusively show whether a part of a genome is a coding region or not to result in phenotypes. Therefore, in the field of proteogenomics, the validation of computational methods is done by exploiting mass spectrometric data. As a result, identification of novel protein coding regions, validation of current gene models, and determination of upstream and downstream regions of genes can be achieved. In this paper, we present new functionality for our proteogenomic tool, PGMiner which performs all proteogenomic steps like acquisition of mass spectrometric data, peptide identification against preprocessed sequence databases, assignment of statistical confidence to identified peptides, mapping confident peptides to gene models, and result visualization. The extensions cover determining proteotypic peptides and thus unambiguous protein identification. Furthermore, peptides conflicting with gene models can now automatically assessed within the context of predicted alternative open reading frames.
Introduction
experimental data. The state-of-the art technology in proteomics for protein identification is mass spectrometry (MS) which provides the opportunity to confirm peptide expression and in turn protein expression. MS data analysis is currently using database search to assign peptide sequences to MS/MS spectra and is limited by sequence availability in databases. With the aid of NGS technology, custom sequence databases can be built by using six-or three-frame translated DNA or RNA sequences. Additionally, available protein sequences, predicted gene models and their derivatives such as alternative spliced forms, exon-exon junction peptides, and single-nucleotide polymorphic sequence variants can be used as databases [2] . Identified peptides can validate gene models but can also allow the discovery of novel coding regions or altered protein sequences that might be related to a certain metabolic state such as disease or environmental stress. In addition to that, correlation of expression among transcriptomics and proteomics expression levels can be investigated for confirmed and novel genes [3] .
The field of proteogenomics exists at this intersection of genomics with proteomics [3] . Proteogenomics studies have been validating existing gene models, have discovered novel gene models, and have shown conflicts with existing gene models [4] - [8] . Moreover, proteogenomics strategies have applications in biomarker discovery [9] - [11] .
Proteogenomic analyses can be broken down into 6 coarse steps which are: 1) data acquisition, 2) building a custom sequence database, 3) performing database search of MS/MS spectra against this database, 4) statistical significance assessment of peptidespectrum matches, 5) mapping statistically confident peptides to the genome while taking into account annotated gene models, and, finally, 6) the evaluation and visualization of results.
In this paper, we offer an extension to PGMiner [12] a user-friendly proteogenomic pipeline developed using the KNIME data analytics platform. PGMiner includes the main steps of proteogenomics in a fully automated manner. The workflow enables users to retrieve mass spectrometry based proteomics data and to perform peptide identification by multi-algorithm support. Finally, PGMiner supports machine aided assessment of gene models by mapping identified peptides and proposal of new gene models.
Related works
Competing approaches with PGMiner also combine analysis steps into one framework for either eukaryotic, prokaryotic organisms, or both [13] . Some of these tools such as the Bacterial Proteogenomic Pipeline (BPP) [14] , Peppy [15] , ProteoAnnotator [16] were developed including a GUI while some of them such as PGTools [17] include command-line modules. pGalaxy [18] was developed on the Galaxy data analysis framework and as such is most comparable to PGMiner. All other solutions require the user to provide mass spectrometry data and genome data and its annotation while PGMiner can retrieve them directly from online repositories. All tools support usage of genomic, transcriptomic and protein sequence databases however automatic translation as in PGMiner is not supported by other approaches. Testing competing implementations, large sequence files led to computational runtime problems and caused termination of the pipelines. To tackle this problem, Peppy generates peptide segments from translated genomic sequences, whilst pGalaxy applies HiRIEF [19] based filtering on generated peptides. Both approaches remove some, potentially, important data from screening whereas PGMiner enables search without removing any sequences. While Peppy supports only one database search algorithm, other tools, like PGMiner, enable multiple algorithms to increase identification confidence and number of correctly identified spectra. Main features of these available pipelines were listed in Table 1 . 
Implementation
PGMiner is a JAVA based proteogenomic workflow developed in the Konstanz Information Miner (KNIME) [20] version 3.1.1 using Java 1.8. KNIME is a data analytics platform including a visual workflow management environment which uses nodes to model processes and edges to indicate data flow. PGMiner addresses needs in different aspects of proteogenomics such as data acquisition from data repositories, peptide identification, peptide mapping, and proposal of new or corrected gene models and finally visualization of these models ( Figure 1 ).
PGMiner has been developed as a KNIME workflow and all novel nodes we added to KNIME are available from our update site: http:/bioinformatics.iyte.edu.tr/PGMiner. Whilst existing pipelines require elaborative installation procedure and have manually controlled or workflow-independent steps, PGMiner has a simple installation procedure and can then be executed in a fully automated manner. Detailed instructions regarding PGMiner installation are described on our web site: http://jlab.iyte.edu.tr/software/PGMiner. Protein identification is a convoluted process since peptides are shared among proteins and other regions of a genome and, therefore, it is hard to unambiguously identify a protein.
PGMiner has been amended with the ability to determine proteotypic peptides. Proteotypic peptides are here defined as peptides occurring only in one location in respect to all mappings of all sequence databases used for PSM establishment to the reference genome. Detection of unambiguously identified proteins and framing other proteins as ambiguous identification is important in large scale studies in order to avoid misinterpretation. PGMiner's proteotypic peptide finder requires gene annotation file in GFF format and sequence files that are compatible with annotation files in terms of sequence accessions. Among selected sequence databases, peptides that are found only in one sequence region are considered as proteotypic. Ambiguities due to different level of associations, i.e. an exonic region might be related to multiple mRNAs and multiple proteins originating from one locus, are resolved in this manner since genomic start and end positions are taken into account.
PGMiner has also been amended to enable prediction of alternative start sites for selected gene models when proteotypic and additional supporting peptides are available. For this, PGMiner mostly follows the linear scanning mechanism where a 40S ribosomal subunit binds to a capped 5'-end of a translation start codon located in an appropriate context [21] - [24] . PGMiner currently only allows the analysis of peptides conflicting with existing gene models, which have been categorized as intronic.
Application
In this study, the human pathogen Toxoplasma gondii RH strain LC-MS/MS collection (PRIDE accession: PXD003603) was used to demonstrate PGMiner's functionality. Three spectral datasets were available in the collection measured by QTOF Impact HD, Maxis 4G (Bruker Daltonics, Bremen, Germany) and Ion Trap amaZon (Bruker Daltonics), respectively. MS/MS spectra with less than 15 peaks were eliminated. The database search tool nodes of PGMiner: OMSSA, MSGF+, and XTandem were used with the following settings: 0.3Da precursor mass tolerance and 0.35Da fragment mass tolerance for Ion Trap amaZon and Maxis 4G spectra; 50 ppm precursor mass tolerance and 0.1Da fragment mass tolerance for QTOF Impact HD. One miscleavage was allowed and carbamidomethylation of cysteine residues and oxidation of methionine residues were set as fixed modifications.
Genome sequences of RH strain and ME49 strain, annotated proteins, annotated transcripts, open-reading frames and coding sequences were retrieved from ToxoDB release 28 (2016-03-23). Since T. gondii is a human pathogen, we filtered human contaminant peptides. To identify those contaminant peptides, we used human ab initio gene models and annotated protein sequences. Nucleotide databases were translated to their six reading frames. In total the databases were 689 MB in size and they were processed into 10 equal size databases by using our database equalizer module [12] . The decoy version of each database was generated by shuffling sequences. The best hit per spectrum was selected among hits retrieved from the 10 databases for each spectrum on a per algorithm basis. This step was carried out for decoy hits, as well. Human contaminant peptide matching spectra were excluded. The summary of the results are presented in Table 2 . Gene models are either supported through peptides, which in turn are supported via PSMs, or have at least one conflicting peptide mapping (Table 3) . Overall, 2,888 unique peptides mapped to 370 unique gene models. Of these peptides 1,052 were identified to be proteotypic. 1,266 peptides were exonic (i.e.: directly supporting annotated gene models) and 13 peptides were overlapping with 5' end of gene models while 31 peptides were overlapping with 3' ends of gene models. 24 gene models had 3' overlapping peptides with 6 of them having also exonic peptides. 2 gene models had only 5' overlapping peptides and 5 gene models had exonic and 5' overlapping peptides. 339 gene models had only peptides mapped to exons. No intergenic peptides were found. In addition to that there was no alternative start site selection transcript in this dataset, however, the approach was developed for human and may not be applicable for T. gondii. 
Discussion
In this study, we presented an extended version of PGMiner, a new proteogenomic workflow tool, which performs automatic assessment of current gene models for eukaryotic and prokaryotic organisms based on mass spectrometric data. The workflow enables users to acquire data from data repositories and to perform peptide identification by employing multiple database search tools against various sequence databases in a parallel manner.
Statistically assessed peptides are further mapped to genome annotations, thereby new gene models can be proposed and current models can be evaluated as confirmed or in need of revision. In order to unambiguously identify gene models, labeling peptides as proteotypic or not is important and the extended version of PGMiner allows users to make such assessment according to user-selected databases. Peptides which are labelled as intronic can be further checked whether they are related to alternative start site selection transcript products.
